Loading…
CIK 0001582844 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("acuta-capital-partners-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| AMYLYX PHARMACEUTICALS INC | COM | $4.0M | 2.7%Prev: 4.7% | 333,258 SH | Decreased |
| ARGEN SE - ADR | SPONSORED ADR | $4.1M | 2.8%Prev: 4.9% | 4,851 SH | Decreased-1,528 SH |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | $6.6M | 4.5%Prev: 5.3% | 84,477 SH | Increased-398 SH |
| CIDARA THERAPEUTICS INC | COM NEW | $19.7M | 13.4%Prev: 14.0% | 89,145 SH | Increased-52,384 SH |
| COMPASS THERAPEUTICS INC | COM | $5.9M | 4.0%Prev: 3.0% | 1,093,300 SH | Increased+253,210 SH |
| DESIGN THERAPEUTICS INC | COM | $1.4M | 1.0% | 150,906 SH | New |
| DIANTHUS THERAPEUTICS INC | COM | $689K | 0.5%Prev: 1.0% | 16,708 SH | Decreased-8,292 SH |
| INHIBRX BIOSCIENCES INC | COM | $1.3M | 0.9%Prev: 0.6% | 16,377 SH | Increased |
| INSMED INC | COM PAR $.01 | $4.5M | 3.1%Prev: 5.7% | 25,878 SH | Decreased-12,714 SH |
| JAZZ PHARMACEUTICALS PLC | SHS USD | $4.9M | 3.3%Prev: 3.4% | 29,008 SH | Increased+3,894 SH |
| LB PHARMACEUTICALS INC | COM SHS | $668K | 0.5%Prev: 0.5% | 30,000 SH | Increased |
| MAZE THERAPEUTICS INC | COM | $829K | 0.6% | 20,000 SH | New |
| MINERVA NEUROSCIENCES | COM NEW | $2.9M | 1.9% | 709,500 SH | New |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | $781K | 0.5% | 59,280 SH | New |
| NUVATION BIO INC -CW27 | *W EXP 07/07/2027 | $30K | 0.0%Prev: 0.0% | 90,832 SH | Increased |
| OCULAR THERAPEUTIX INC | COM | $12.8M | 8.7%Prev: 14.1% | 1,052,995 SH | Decreased-112,211 SH |
| OCULIS HOLDING AG | ORDINARY SHARES | $2.0M | 1.4%Prev: 1.8% | 101,777 SH | Increased |
| PASITHEA THERAPEUTICS CORP | COM NEW | $581K | 0.4% | 450,000 SH | New |
| PRAXIS PRECISION MEDICINES I | COM | $24.5M | 16.6%Prev: 2.7% | 83,036 SH | Increased+33,285 SH |
| REVOLUTION MEDICINES INC | COM | $670K | 0.5%Prev: 0.4% | 8,411 SH | Increased |
| SURROZEN INC | COM NEW | $4.0M | 2.7%Prev: 2.4% | 178,415 SH | Increased |
| SUTRO BIOPHARMA INC | COM | $780K | 0.5% | 67,451 SH | New |
| TANGO THERAPEUTICS INC | COM | $2.5M | 1.7% | 282,732 SH | New |
| TAYSHA GENE THERAPIES INC | COM SHS | $2.5M | 1.7%Prev: 1.5% | 454,827 SH | Increased |
| TERNS PHARMACEUTICALS INC | COM | $25.7M | 17.5%Prev: 3.9% | 637,095 SH | Increased+134,298 SH |
| UNICYCIVE THERAPEUTICS INC | COM | $346K | 0.2%Prev: 0.3% | 59,985 SH | Increased |
| UNITED THERAPEUTICS CORP | COM | $1.1M | 0.8%Prev: 1.0% | 2,296 SH | Increased |
| VERASTEM INC | COM NEW | $1.1M | 0.8%Prev: 1.3% | 143,446 SH | Decreased |
| WHITEHAWK THERAPEUTICS INC | COM | $8.3M | 5.6%Prev: 6.7% | 3,410,402 SH | Increased |
| ZYMEWORKS INC | COM | $2.1M | 1.4%Prev: 1.4% | 80,143 SH | Increased |
| 13F-HR |
| 0001104659-26-096822 |
| $143.5M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001104659-25-078732 | $71.6M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001104659-26-062163 | $141.8M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001104659-25-048878 | $86.2M | View |